BioGenex Laboratories — Cyborg Score 7/10

Strong
Molecular pathology diagnostic systems

Strategic Profile

BioGenex's industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. The company prides itself on delivering innovative products, years ahead of the competition in the field of immunohistochemistry (IHC) and in situ hybridization (ISH).

Cyborg Score Rationale

Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally. The company has strong patent protections and a diversified global distribution network, but private company status and limited recent financial disclosure constrain visibility into growth trajectory and market share dynamics.

Top Insights

  • Product range includes primary antibodies, high sensitive detection kits, automated systems, probes, antigen retrieval systems, and histology stains.
  • Flagship products include Xmatrx® systems, i6000™ systems, i500 Plus™, NanoVIP®, Neuvo, EZ-Retriever®, IHC primary antibodies, microRNA probes, and IHC/ISH Detection kits.
  • Company holds ISO 13485 (2016), ISO 9001 (2015), cGMP, and IVD–CE certifications, indicating strong regulatory compliance posture.
  • BioGenex was established in 1981 in San Ramon, CA with a mission to provide affordable solutions for life science research and personalized medicine.

Named Competitors

  • Roche Diagnostics — Molecular pathology and precision diagnostics automation systems
  • Illumina — Next-generation sequencing and molecular diagnostics platforms
  • Qiagen — Sample preparation and molecular pathology testing systems
  • Agilent Technologies — Pathology informatics and molecular diagnostics instrumentation

Recent Developments

  • (June 2025) Global distribution expanded to 70+ distributors across 47 countries with regional manufacturing in Fremont and Hyderabad, India
  • (April 2026) Company website updated confirming active operations and expanded customer support infrastructure across Fremont, Hyderabad, and Shanghai

Open the full interactive BioGenex Laboratories report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →